Wells Fargo & Company Care Dx, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Care Dx, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 22,675 shares of CDNA stock, worth $569,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,675

Previous 21,214 6.89%

Holding current value

$569,596

Previous $329,000 114.89%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$14.41 - $33.99 $21,053 - $49,659	1,461 Added 6.89%	22,675 $707,000
Q2 2024 Aug 13, 2024	BUY	$7.56 - $16.15 $16,873 - $36,046	2,232 Added 11.76%	21,214 $329,000
Q1 2024 May 10, 2024	BUY	$7.96 - $12.37 $18,745 - $29,131	2,355 Added 14.16%	18,982 $201,000
Q4 2023 Feb 09, 2024	SELL	$4.9 - $12.86 $256,402 - $672,925	-52,327 Reduced 75.89%	16,627 $199,000
Q3 2023 Nov 13, 2023	SELL	$7.0 - $11.26 $92,722 - $149,149	-13,246 Reduced 16.11%	68,954 $482,000
Q2 2023 Aug 15, 2023	SELL	$7.61 - $9.46 $2,808 - $3,490	-369 Reduced 0.45%	82,200 $698,000
Q1 2023 May 12, 2023	BUY	$8.83 - $17.61 $685,313 - $1.37 Million	77,612 Added 1565.71%	82,569 $754,000
Q4 2022 Feb 13, 2023	SELL	$10.88 - $20.05 $71,775 - $132,269	-6,597 Reduced 57.1%	4,957 $56,000
Q3 2022 Nov 14, 2022	BUY	$16.06 - $26.39 $3,404 - $5,594	212 Added 1.87%	11,554 $196,000
Q2 2022 Aug 12, 2022	SELL	$20.49 - $39.72 $1.63 Million - $3.15 Million	-79,309 Reduced 87.49%	11,342 $244,000
Q1 2022 May 16, 2022	SELL	$28.19 - $46.6 $1.46 Million - $2.42 Million	-51,951 Reduced 36.43%	90,651 $3.35 Million
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $14.2 Million - $25.4 Million	-344,648 Reduced 70.73%	142,602 $6.49 Million
Q3 2021 Nov 15, 2021	BUY	$59.15 - $91.99 $3.57 Million - $5.56 Million	60,429 Added 14.16%	487,250 $30.9 Million
Q2 2021 Aug 16, 2021	SELL	$63.02 - $95.11 $466,474 - $704,004	-7,402 Reduced 1.7%	426,821 $39.1 Million
Q1 2021 May 13, 2021	BUY	$57.62 - $95.6 $922,208 - $1.53 Million	16,005 Added 3.83%	434,223 $29.6 Million
Q4 2020 Feb 09, 2021	BUY	$41.43 - $77.09 $2.3 Million - $4.28 Million	55,455 Added 15.29%	418,218 $30.3 Million
Q3 2020 Nov 05, 2020	SELL	$30.88 - $37.94 $237,868 - $292,251	-7,703 Reduced 2.08%	362,763 $13.8 Million
Q2 2020 Aug 13, 2020	SELL	$18.95 - $35.43 $86,412 - $161,560	-4,560 Reduced 1.22%	370,466 $13.1 Million
Q1 2020 May 14, 2020	BUY	$13.94 - $28.25 $5.23 Million - $10.6 Million	375,026 New	375,026 $8.19 Million

Others Institutions Holding CDNA

# of Institutions

219

Shares Held

51.1M

Call Options Held

97.3K

Put Options Held

43.3K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.34B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Care Dx, Inc. Transaction History